Mark Nawacki
Mark Nawacki joined Paladin in September 2003 and holds responsibility for all business, corporate and product development activities at Paladin Labs Inc., a leading Canadian specialty pharmaceutical company. Since joining Paladin, Mark has concluded over 50 business development deals and has led Paladin’s international expansion and emerging markets strategy, including the investment in Pharmaplan of South Africa. Other key accomplishments include the establishment of Paladin’s Licensing Advisory Board (LAB) and multiple internal process improvements to improve the deal flow and efficacy of Paladin’s evaluation and execution of business development transactions.
Prior to joining Paladin, Mark held progressively senior leadership positions at Pharmacia, a global top 10 pharmaceutical company that is now part of Pfizer Inc. While at Pharmacia, Mr. Nawacki was responsible for Canadian business development initiatives and was instrumental in the design and implementation of a portfolio planning process that guided strategic planning and business development activities.
Mr. Nawacki began his career as a consultant in Arthur Andersen’s Canadian financial advisory services practice, and later spent time in the consumer packaged goods industry working with Pillsbury where he was responsible for financial management of the Green Giant business in Canada.
Mr. Nawacki holds a BA in International Relations and Russian and East European Studies from the University of Toronto (Trinity), MBA also from the University of Toronto, and is a Canadian-designated Chartered Accountant. He is an active speaker on the subject of licensing and business development, is a member of the Board of Trustees of the Licensing Executive Society (USA & Canada) and is a former President and Board Member of the Canadian Healthcare Licensing Association.
or